Publications by authors named "Martin Buess"

Claim this Profile
T
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.
Dominic Schmid, Bettina Sobottka, Massimiliano Manzo, Marta Trüb, Katharina Leonards, Martin Buess

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusual relapse dynamics in EGFR-mutated lung adenocarcinoma uncovered by genomic profiling: Insights from a case report.
Luca Roma, Obinna Chijioke, Dominik Valentin Flury, Gregor Jan Kocher, Sebastian Ott, Martin Buess

Lung Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen Deprivation Therapy for Intracranial Metastasis of a Salivary Duct Carcinoma: Case Report.
Manuel Rösch, Christian Bieg, Spasenija Savic, Martin Buess

Case Rep Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Hospitalized Cancer Patients with Hypernatremia: A Retrospective Case-Control Study.
Jessica Del Rio, Martin Buess

Curr Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial.
Sacha I Rothschild, Alfred Zippelius, Eric I Eboulet, Spasenija Savic Prince, Daniel Betticher, Martin Buess

J Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancer.
Till Wallrabenstein, Jessica Del Rio, Arnoud J Templeton, Martin Buess

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer.
Ilaria Alborelli, Katharina Leonards, Sacha I Rothschild, Laura P Leuenberger, Spasenija Savic Prince, Martin Buess

J Pathol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial cell-derived nidogen-1 inhibits migration of SK-BR-3 breast cancer cells.
Daniela A Ferraro, Francesca Patella, Sara Zanivan, Cinzia Donato, Nicola Aceto, Martin Buess

BMC Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Treatment of Isolated Locoregional Breast Cancer Recurrences.
Wolfgang Harms, Andreas Geretschläger, Corinne Cescato, Martin Buess, Dieter Köberle

Breast Care (Basel)· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BMP2 response pattern in human lung fibroblasts predicts outcome in lung adenocarcinomas.
Michal Rajski, Annika Saaf, Martin Buess

BMC Med Genomics· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality.
Michael Schlumpf, Claude Fischer, Diana Naehrig, Christoph Rochlitz, Martin Buess

BMC Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the EGFR mutation status in head and neck squamous cell carcinoma before treatment with Gefitinib.
Sven Bontognali, Miklos Pless, Martin H Brutsche, Claude Fischer, Christoph Rochlitz, Martin Buess

Onkologie· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global gene expression analysis of the interaction between cancer cells and osteoblasts to predict bone metastasis in breast cancer.
Michal Rajski, Brigitte Vogel, Florent Baty, Christoph Rochlitz, Martin Buess

PLoS One· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
Florent Baty, Michaël Facompré, Sergio Kaiser, Martin Schumacher, Miklos Pless, Martin Buess

Am J Respir Crit Care Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-I induced genes in stromal fibroblasts predict the clinical outcome of breast and lung cancer patients.
Michal Rajski, Rosanna Zanetti-Dällenbach, Brigitte Vogel, Richard Herrmann, Christoph Rochlitz, Martin Buess

BMC Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer.
Martin Buess, Michal Rajski, Brigitte M L Vogel-Durrer, Richard Herrmann, Christoph Rochlitz

Neoplasia· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of heterotypic interaction effects in vitro to deconvolute global gene expression profiles in cancer.
Martin Buess, Dimitry S A Nuyten, Trevor Hastie, Torsten Nielsen, Robert Pesich

Genome Biol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.
Robert Zeiser, Vu H Nguyen, Jing-Zhou Hou, Andreas Beilhack, Elizabeth Zambricki, Martin Buess

Blood· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.
Robert Zeiser, Vu H Nguyen, Andreas Beilhack, Martin Buess, Stephan Schulz

Blood· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and predictive relevance of DNAM-1, SOCS6 and CADH-7 genes on chromosome 18q in colorectal cancer.
Iana Storojeva, Jean-Louis Boulay, Pierluigi Ballabeni, Martin Buess, Luigi Terracciano

Oncology· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STRAP is a strong predictive marker of adjuvant chemotherapy benefit in colorectal cancer.
Martin Buess, Luigi Terracciano, Jurgen Reuter, Pierluigi Ballabeni, Jean-Louis Boulay

Neoplasia· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amplification of SKI is a prognostic marker in early colorectal cancer.
Martin Buess, Luigi Terracciano, Jürgen Reuter, Pierluigi Ballabeni, Jean-Louis Boulay

Neoplasia· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obstructive jaundice caused by enteropathy-associated T-cell lymphoma in a patient with celiac sprue.
Martin Buess, Michael Steuerwald, Werner Wegmann, Madeleine Rothen

J Gastroenterol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis